Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04291638 · ClinicalTrials.gov registry record · NA
Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism
A NA study, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04291638 is a NA study that has completed, run by Florida International University. The registered enrollment target is 11 participants.
The verdict
NCT04291638, a NA study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study sought to evaluate an innovative post-acute continuation/transition planning treatment strategy that leveraged an in-person intensive treatment followed by online, videoconferencing-based "booster" sessions for youth with selective mutism (SM). Twenty children between the ages of 4 and 10 and their caregivers were scheduled to participate in an in-person intensive group behavioral treatment (IGBT) for SM and subsequently randomized to receive either (a) six, biweekly, hour-long, videoconferencing-delivered booster sessions or (b) no additional treatment for 12 weeks. Due to COVID-19-related physical distancing restrictions, the study team was unable to provide in-person services. Thus, the clinical trial was converted to an open-trial design focused on evaluating remote treatment options (i.e., remotely delivered caregiver training sessions and/or a remotely delivered IGBT) for these families. All families retained in the study have or will participate(d) in assessments at the following time points: Intake (i.e., 4-5 months prior to the remote IGBT); Baseline (i.e., 1 month prior to the IGBT), Post-IGBT (i.e., 2 weeks following the IGBT), and School Year Follow Up (i.e., 16 weeks following the IGBT).
Interventions
- BEHAVIORAL Remote Caregiver Training
- BEHAVIORAL Remote Intensive Group Behavioral Treatment (IGBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2020-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04291638
The ClinicalTrials.gov registry entry for NCT04291638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Remote Caregiver Training is the first listed.
NCT04291638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04291638 about?
NCT04291638 is a clinical study titled "Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism". This study sought to evaluate an innovative post-acute continuation/transition planning treatment strategy that leveraged an in-person intensive treatment followed by online, videoconferencing-based "booster" sessions for youth with selective mutism (SM). Twenty children between the ages of 4 and 10...
What is the current status of trial NCT04291638?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2020-03-06. Estimated completion is 2020-12-07.
What interventions are being tested in trial NCT04291638?
The interventions under investigation include: Remote Caregiver Training (BEHAVIORAL), Remote Intensive Group Behavioral Treatment (IGBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04291638?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.